AI Enhancements in the US Point of Care Diagnostics Market
Based on Fortune Business Insights’ report, the US point of care diagnostics market share sector attained a worth of USD 13.47 billion in 2022. Forecasts indicate a promising path ahead, foreseeing a Compound Annual Growth Rate (CAGR) of 7.9% from 2022 to 2030. This trajectory will culminate in a noteworthy achievement of by 2030, highlighting considerable opportunities within this flourishing high-volume industry. North America dominated the market in 2022.
Request a Free Sample PDF Brochure of US Point of Care Diagnostics Market: https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/108003
In a recent study, Fortune Business Insights presents the nitty-gritty of the global US Point of Care Diagnostics Market considering 2024–2032 as the stipulated timeframe. The business report highlights the drivers, restraints, opportunities, and market growth trends. Further, all the market shares associated with the market as well as the segments are expressed in terms of value and volume.
Top Companies in the US Point of Care Diagnostics Market:
- F. Hoffmann-La Roche Ltd (Switzerland)
- Thermo Fisher Scientific Inc. (US)
- Abbott Laboratories (US)
- Quest Diagnostics Incorporated (US)
- BD (US)
- bioMérieux SA (France)
- Cardinal Health, Inc. (US)
- Cepheid (US)
- Trinity Biotech (Ireland)
- Quidel Corporation (US)
- Bio-Rad Laboratories Inc. (US)
The US Point of Care Diagnostics Market study outlines the key regions of North America, Latin America, Europe, East Asia, and Japan along with the countries contributing the most in the respective regions. The report presents detailed insights about each market player, including SWOT analysis, main market information, market share, revenue, pricing, and gross margin.
US Point of Care Diagnostics Market Dynamics:
- Increased Demand for Rapid Testing: The US point-of-care diagnostics market experiences growth due to increased demand for rapid and convenient testing solutions, driven by the need for timely diagnosis, treatment initiation, and disease management across various healthcare settings.
- Expansion of Testing Capabilities: Point-of-care diagnostics continue to expand beyond traditional settings such as hospitals and clinics to include pharmacies, urgent care centers, and retail clinics, enhancing accessibility and convenience for patients while driving market growth.
- Technological Advancements: Advances in technology, including miniaturization, automation, and integration with digital health platforms, are driving innovation in point-of-care diagnostic devices, enabling real-time testing, data connectivity, and remote monitoring capabilities, reshaping the market landscape.
- Emphasis on Infectious Disease Testing: The US point-of-care diagnostics market sees significant demand for rapid testing solutions for infectious diseases, including respiratory viruses, sexually transmitted infections, and emerging pathogens, fueled by public health concerns and the need for outbreak control measures.
- Regulatory Landscape and Market Access: Regulatory considerations, including FDA approvals, CLIA waivers, and reimbursement policies, play a critical role in market access and adoption of point-of-care diagnostic technologies, influencing product development, commercialization strategies, and competitive dynamics among industry players.
The insights for each vendor consist of:
- Company profile
- SWOT analysis
- Main market information
- Market share
- Revenue, pricing, and gross margin
Crucial insights in the US Point of Care Diagnostics Market research:
- Underlying macro- and microeconomic factors impacting the growth of the US Point of Care Diagnostics Market.
- Basic overview of US Point of Care Diagnostics Market, including market definition, classification, and applications.
- Scrutinization of each US Point of Care Diagnostics Market player based on mergers & acquisitions, R&D projects, and product launches.
- Adoption trend of US Point of Care Diagnostics Market across various industries.
- Important regions and countries offer lucrative opportunities to US Point of Care Diagnostics Market stakeholders.
Important regions covered in the US Point of Care Diagnostics Market report include:
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa
Table of Contents:
- Introduction
- Research Scope
- Customer Segmentation
- Data Gathering Strategies
- Key Definitions & Caveats
- Executive Summary
- Market Dynamics
- US Point of Care Diagnostics Market Drivers
- US Point of Care Diagnostics Market Restraints
- Market Opportunities
- Key Insights
- Value Chain
- Major M&A moves and game-changing partnerships.
- Covid-19 Impact
- Future of the Healthcare Industry
- Competitive Landscape
- Mergers and Acquisitions, Joint Ventures, Collaborations, and Agreements
- US Point of Care Diagnostics Market Growth Size 2024
- Strategies Adopted by Leading Players
- Company Profiles (Overview, Financials, Products and Services, and Recent Developments)
- Disclaimer
TOC Continued…!
FAQ’s
- How big is the US Point of Care Diagnostics Market?
- What factors are influencing the US Point of Care Diagnostics Market growth in North America?
- Who are the key US Point of Care Diagnostics Market players?